VANI
Vivani Medical, Inc.Company Information
- Company Name
- Vivani Medical, Inc.
- CIK
- CIK0001266806
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- VANI: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- VANI
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-07-15
- Last sale
- —
- Shares purchased (TTM)
- 23,091,841
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 4,730,234
- Shares outstanding
- 87,090,000
- Ownership
- 5.43%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 11.19%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 20 | 20 | 16 | 3 | 7 | 13 | 18 | 20 | 25 | 30 | 21 | 25 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 22 | 22 | 18 | 4 | 9 | 15 | 20 | 21 | 26 | 32 | 23 | 31 | ||||||
| Receivables Net Current | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 6 | ||||||
| Property Plant And Equipment Net | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | ||||||
| Operating Lease Right Of Use Asset | 16 | 17 | 17 | 17 | 17 | 18 | 18 | 18 | 19 | 19 | 20 | 20 | ||||||
| Restricted Cash Noncurrent | - | - | 1 | - | - | - | 1 | - | - | - | - | - | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | - | - | - | - | - | - | 1 | - | - | - | 1 | - | ||||||
| Other Assets Noncurrent | 1 | 1 | - | 1 | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 42 | 42 | 39 | 25 | 29 | 35 | 42 | 43 | 48 | 54 | 46 | 53 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Accrued Liabilities Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | ||||||
| Litigation Reserve Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Employee Related Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | ||||||
| Operating Lease Liability Current | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | 16 | 16 | 17 | 17 | 17 | 18 | 18 | 18 | 19 | 19 | 19 | 20 | ||||||
| Liabilities | 23 | 23 | 24 | 24 | 24 | 24 | 24 | 25 | 24 | 25 | 25 | 27 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 19 | 19 | 16 | 1 | 5 | 12 | 18 | 18 | 24 | 29 | 21 | 26 | ||||||
| Additional Paid In Capital | 181 | 174 | 164 | 143 | 140 | 140 | 139 | 134 | 134 | 133 | 119 | 119 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -162 | -155 | -149 | -142 | -135 | -128 | -122 | -116 | -110 | -104 | -98 | -92 | ||||||
| Liabilities And Stockholders Equity | 42 | 42 | 39 | 25 | 29 | 35 | 42 | 43 | 48 | 54 | 46 | 53 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Authorized | - | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 89 | 85 | 76 | 62 | 59 | 59 | 59 | 55 | 55 | 55 | 51 | 51 | ||||||
| Shares Outstanding | 89 | 85 | 76 | 62 | 59 | 59 | 59 | 55 | 55 | 55 | 51 | 51 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVivani Medical, Inc. (VANI) — SEC Financial Statements & Analysis
Vivani Medical, Inc. (VANI) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Vivani Medical, Inc. trades on Nasdaq as: VANI. Vivani Medical, Inc. (VANI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Vivani Medical, Inc. carries a market cap of $107.99M, a P/E ratio of -4.10x, a P/B ratio of 5.69x, an enterprise value of $88.10M, and an EV/EBITDA multiple of -3.29x. On profitability, it posts a Return on Equity (ROE) of -220.40%, a Return on Assets (ROA) of -74.60%, and a Return on Invested Capital (ROIC) of -5321.71%. Per share, it reports EPS of $-0.30, diluted EPS of $-0.30, free cash flow per share of $-0.30, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 3.04% year-over-year, and EPS growth of -29.91% year-over-year. On the balance sheet, it maintains a current ratio of 3.25x, a quick ratio of 3.09x, working capital of $14.98M, a debt-to-equity ratio of 1.20x, a debt ratio of 0.54, free cash flow of $-26.50M (TTM), and net debt of $-19.89M. Figures sourced from SEC EDGAR.
- Market Cap
- $107.99M
- P/E TTM
- -4.10x
- EPS TTM
- $-0.30
- P/B TTM
- 5.69x
- ROE TTM
- -220.40%
- ROA TTM
- -74.60%
- Debt To Equity
- 1.20x
- Free Cash Flow TTM
- $-26.50M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Vivani Medical, Inc. in?
Vivani Medical, Inc. (VANI) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does VANI trade on?
Vivani Medical, Inc. (VANI) trades on the Nasdaq.
Where is Vivani Medical, Inc. incorporated?
Vivani Medical, Inc. is incorporated in DE.
When was Vivani Medical, Inc. (VANI)'s most recent SEC filing?
Vivani Medical, Inc. (VANI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is VANI's market cap?
Vivani Medical, Inc. (VANI) has a market capitalization of $107.99M as of 2026-06-30.
What is VANI's EPS (earnings per share)?
Vivani Medical, Inc. (VANI)'s trailing twelve month EPS is $-0.30 as of 2026-06-30.
What is VANI's ROE (return on equity)?
Vivani Medical, Inc. (VANI)'s trailing twelve month Return on Equity (ROE) is -220.40% as of 2026-06-30.
What is VANI's ROA (return on assets)?
Vivani Medical, Inc. (VANI)'s trailing twelve month Return on Assets (ROA) is -74.60% as of 2026-06-30.
What is VANI's ROIC (return on invested capital)?
Vivani Medical, Inc. (VANI)'s trailing twelve month Return on Invested Capital (ROIC) is -5321.71% as of 2023-09-30.
What is VANI's EV/EBITDA?
Vivani Medical, Inc. (VANI)'s trailing twelve month EV/EBITDA is -3.29x as of 2026-06-30.